Dr Agarwal’s Healthcare IPO: Opening from January 29; Test all the small print together with worth band, GMP, itemizing date – INA NEWS
Dr Agarwal’s Healthcare IPO: Cash might be invested within the public challenge of Dr. Aggarwal’s Healthcare, which offers eye care companies, from January 29. The IPO will shut on January 31. Anchor buyers will be capable to bid on January 28. Itemizing of shares can occur on BSE, NSE on fifth February. Even earlier than the opening of the problem, the corporate’s shares are buying and selling at a premium of Rs 30 or 7.46 per cent within the higher worth band of Rs 402 within the grey market. The grey market is an unauthorized market the place shares of an organization commerce till its itemizing.
The worth band for bidding in IPO has been fastened at Rs 382-402 per share. The lot dimension is 35 shares. The corporate desires to boost roughly Rs 3,027.26 crore from the IPO. TPG and Temasek Holdings have additionally invested in Dr. Aggarwal’s Healthcare. Dr Agarwals Healthcare is the dad or mum firm of listed firm Dr Agarwals Eye Hospital. It holds 71.90 p.c stake in Dr. Aggarwal’s Eye Hospital.
What number of shares bought in IPO
The IPO will see issuance of latest shares price as much as Rs 300 crore, together with a suggestion on the market (OFS) of 6.78 crore fairness shares price Rs 2,727.26 crore from promoters and different shareholders. Amongst those that bought shares within the OFS have been Arvon Investments Pvt Ltd, Claymore Investments (Mauritius) Pvt Ltd and Hyperion Investments Pvt Ltd.
TPG holds 33.75 per cent stake in Dr Aggarwal’s Well being Care via Hyperion Investments Pte, whereas Temasek holds 12.45 per cent via Arvon Investments Pte and 15.73 per cent via Claymore Investments (Mauritius) Pte. The promoters of the corporate are Amar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal, Ashwin Agarwal, Dr. Agarwal’s Eye Institute, Farah Agarwal and Urmila Agarwal.
IPOs This Week: Solely 2 new IPOs within the week ranging from January 27, 6 corporations will likely be listed within the inventory market.
What sort of eyecare companies does the corporate present?
With 165 amenities in India and 15 globally (together with 9 in Africa), Tamil Nadu-based Dr. Agarwal’s Healthcare affords eyecare companies akin to cataract, refractive and different surgical procedures. Other than this, it additionally sells spectacles, contact lenses and equipment, and eyecare associated pharma merchandise. Its share within the whole eyecare service chain market in India throughout FY 2024 was about 25 p.c.
How will Dr Agarwal’s Healthcare IPO cash be used?
The corporate will use Rs 195 crore of the cash raised by issuing new shares within the IPO to repay the mortgage. The remaining cash will likely be used for normal company functions and inorganic acquisitions. The service provider bankers to the problem are Kotak Mahindra Capital, Jefferies, Morgan Stanley and Motilal Oswal.
Income elevated by 31% in FY24
Dr Agarwal’s Healthcare had a consolidated debt of Rs 384 crore by July 2024. The corporate’s web revenue declined by 7.9 p.c to Rs 95 crore in FY 2024. A 12 months in the past it was Rs 103.2 crore. Income from operations grew 30.9 per cent to Rs 1,332 crore in FY23 from Rs 1,018 crore. EBITDA grew 34 per cent to Rs 362.3 crore and margin expanded 0.6 bps to 27.2 per cent.
Dorf-Ketal Chemical compounds India is bringing IPO of тВ╣ 5000 crore, there will likely be new shares price тВ╣ 1500 crore; draft deposit
Kotak Mahindra Capital Firm, Morgan Stanley India Firm, Jefferies India, Motilal Oswal Funding Advisors are the ebook operating lead managers for the IPO. Kfin Applied sciences is the registrar. 50 p.c of the IPO is reserved for certified institutional buyers, 35 p.c for retail buyers and 15 p.c for non-institutional buyers.
Dr Agarwal’s Healthcare IPO: Opening from January 29; Test all the small print together with worth band, GMP, itemizing date
рджреЗрд╢ рджреБрдирд┐рдпрд╛рдВ рдХреА рдЦрдмрд░реЗрдВ рдкрд╛рдиреЗ рдХреЗ рд▓рд┐рдП рдЧреНрд░реБрдк рд╕реЗ рдЬреБреЬреЗрдВ,
#INA #INA_NEWS #INANEWSAGENCY
Copyright Disclaimer :-Beneath Part 107 of the Copyright Act 1976, allowance is made for тАЬtruthful useтАЭ for functions akin to criticism, remark, information reporting, educating, scholarship, and analysis. Honest use is a use permitted by copyright statute that may in any other case be infringing., academic or private use suggestions the steadiness in favor of truthful use.